on September 01, 2026
Copper, chemical symbol Cu and atomic number 29, is an essential trace element belonging to the transition metals. Its biological importance derives primarily from its ability to reversibly alternate between different oxidation states, mainly Cu(I), or cuprous copper, and Cu(II), or cupric copper. This characteristic makes copper particularly suited to participate in electron transfer reactions, which are fundamental for energy production, cellular respiration, and numerous redox processes.
The same property that makes copper indispensable to life also represents a potential source of biological risk. A metal capable of transferring electrons with high efficiency can indeed promote unwanted reactions when present in its free or poorly controlled form. For this reason, the organism has developed an extremely sophisticated system of transport proteins, intracellular chaperones, metalloproteins, and enzymes that maintain the concentration of free copper at extremely low levels.
The fundamental concept of copper biology is therefore that of homeostasis: it is not enough to ingest copper, but it is necessary that the metal be absorbed, distributed, utilized, stored, and eliminated in a strictly regulated manner. Both deficiency and excessive accumulation can compromise the function of different organs and systems. More recent knowledge has also expanded the biological role of copper, showing its involvement not only as an enzymatic cofactor, but also in the regulation of cell signaling, autophagy, differentiation, and specific forms of cell death regulated by copper metabolism.
In the human body, copper is present in relatively small quantities, but it participates in a very large number of biological processes. It is necessary for the proper functioning of enzymes involved in mitochondrial respiration, antioxidant defense, iron metabolism, connective tissue synthesis, pigmentation, and the maturation of the nervous system.
Among the main copper-dependent proteins are mitochondrial cytochrome c oxidase, essential for energy production through oxidative phosphorylation, superoxide dismutase 1, involved in the neutralization of the superoxide radical, lysyl oxidases, important for the maturation of collagen and elastin, and various oxidases and monooxygenases involved in the metabolism of neurotransmitters and other biologically active molecules.
Copper also plays a particularly important role in iron metabolism. Ceruloplasmin and other multicopper ferroxidases are necessary for the oxidation of iron from Fe(II) to Fe(III), a transformation indispensable for iron to be efficiently associated with transferrin and transported in the bloodstream. For this reason, an alteration in copper homeostasis can also manifest as alterations in erythropoiesis and iron metabolism. The relationship between copper and iron is therefore a particularly significant example of the interdependence between essential trace elements.
From a nutritional standpoint, copper is introduced mainly through food. Legumes, nuts, seeds, whole grains, cocoa, some vegetables, mollusks, and other foods of marine origin can contribute to dietary intake. However, the availability of copper depends not only on the quantity present in food, but also on the overall composition of the diet, the presence of other minerals, and the physiological and pathological conditions of the gastrointestinal tract.
Nutritional reference values may differ among various scientific authorities. In the European Union, the EFSA has established an adequate intake for adults of 1.6 mg per day for men and 1.3 mg per day for women. These values must be interpreted in the context of an overall balanced diet and do not represent an indication to seek high intakes through indiscriminate supplementation.
Copper absorption occurs mainly in the upper part of the small intestine. Before entering the cell, copper must be maintained in a chemical form compatible with transport systems. One of the main transporters involved in cellular entry is CTR1, encoded by the SLC31A1 gene, which primarily transports copper in the Cu(I) form.
CTR1 is present in various tissues and represents one of the main entry points of copper into cells. Its structure allows the coordination of the metal through amino acid residues particularly rich in methionine and other sequences capable of binding copper. Transport should not be considered a simple passive passage through the membrane: instead, it represents the first level of a highly regulated system that links the extracellular availability of the metal to the metabolic demand of the cell.
After intestinal absorption, copper reaches the liver through the portal circulation. The liver represents the main organ controlling systemic copper homeostasis and simultaneously performs functions of uptake, storage, utilization, distribution, and elimination.
This centrality of the liver is fundamental to understanding the metabolism of the trace element. The hepatocyte does not simply act as a passive storage site, but as a dynamic regulatory center. Copper reaching the liver can be used for the synthesis of cuproproteins, incorporated into ceruloplasmin, transferred to other intracellular compartments, temporarily sequestered by high-affinity proteins, or eliminated through bile when the intake exceeds the body's needs.
Once inside the hepatocyte, copper does not circulate freely in the cytoplasm. The presence of free copper would indeed be potentially harmful, as the metal could participate in inappropriate redox reactions, interact with non-target proteins, alter biological membranes, and contribute to the production of reactive oxygen species.
To prevent this situation, copper is rapidly associated with molecules and proteins that control its distribution. Metallothioneins can contribute to sequestration and cell protection under conditions of increased copper availability, while specific chaperones direct the metal toward precise metabolic destinations. The concept of copper chaperones is fundamental: these proteins do not simply transport copper from one point to another, but ensure that the transfer occurs selectively, avoiding the presence of high concentrations of reactive copper in the cytosol.
Among the main intracellular copper distribution systems are ATOX1, CCS, and the proteins involved in the mitochondrial traffic of the metal.
ATOX1, named Antioxidant Protein 1, represents one of the main cytosolic copper chaperones. After binding Cu(I), ATOX1 can transfer it to the copper transporter ATPases ATP7A and ATP7B. In the liver, ATP7B plays a central role because it links intracellular copper metabolism to the synthesis of cuproproteins and its biliary elimination.
CCS, on the other hand, plays a fundamental role in delivering copper to cytosolic superoxide dismutase SOD1. The correct incorporation of copper into SOD1 is necessary for the full functionality of the enzyme, which participates in the conversion of the superoxide radical into less reactive products.
Copper destined for the mitochondria is used mainly for the assembly and functioning of cytochrome c oxidase, complex IV of the respiratory chain. This link explains why major alterations in copper homeostasis can compromise cellular energy production. Current knowledge indicates a mitochondrial traffic system more complex than initial models and includes various chaperones and transporters that cooperate to ensure the correct availability of the metal to mitochondrial enzymes.
The role of ceruloplasmin deserves particular attention. This glycoprotein is synthesized mainly by the liver and belongs to the multicopper ferroxidase family. Its function does not simply consist in the transport of copper in the blood. Ceruloplasmin is, in fact, a fundamental enzymatic protein in the interaction between copper metabolism and iron metabolism.
Ceruloplasmin contains several copper atoms incorporated during its biosynthesis. These metal centers allow the protein to perform redox reactions, in particular the oxidation of ferrous iron, Fe(II), to ferric iron, Fe(III). Iron in the Fe(III) form can therefore be associated more efficiently with transferrin.
This process is important mainly for the mobilization of iron from tissues. Multicopper ferroxidases indeed contribute to the proper functioning of the ferroportin-transferrin axis, facilitating the export of iron from cells and its subsequent transport in the blood. Ceruloplasmin plays a relevant role in the liver and the central nervous system, while other copper-dependent ferroxidases perform specific functions in other areas, such as the intestine.
In the liver, the incorporation of copper into ceruloplasmin depends crucially on the function of ATP7B. This protein belongs to the P1B-type ATPase family, specialized in the transport of transition metals through membranes using energy derived from ATP hydrolysis.
Under conditions of normal copper availability, ATP7B is located mainly in intracellular compartments of the secretory system, in particular in the trans-Golgi network area. Here it receives copper through the transfer system involving ATOX1, and transfers it into the lumen of secretory compartments where it can be incorporated into newly synthesized cuproproteins, including ceruloplasmin.
When intracellular copper availability increases, ATP7B changes its localization and participates in the transfer of copper toward compartments involved in its elimination. In the liver, this process is essential for the transport of copper toward the bile canaliculi and, therefore, for excretion through bile.
Biliary elimination represents the main physiological pathway for removing excess copper from the body. This is one of the reasons why the liver is the main target organ of pathologies characterized by alterations in copper metabolism. When the biliary transport system is compromised, the metal tends to progressively accumulate in hepatocytes, increasing the risk of cellular damage.
The mechanism of copper transporter ATPases is closely linked to ATP hydrolysis. These proteins possess specialized functional domains that coordinate ATP binding, the phosphorylation of specific amino acid residues, and the conformational changes necessary to transfer copper across the membrane.
The transient phosphorylation of an aspartate residue represents a characteristic step of P-type ATPases. The energy stored in the phosphorylated intermediate is used to change the protein's conformation and allow the passage of copper from one side of the membrane to the other. This process represents an example of how the chemical energy of ATP can be converted into the active transport of an essential metal.
ATP7A and ATP7B perform different roles in the body. ATP7A is particularly important for the transfer of copper across the intestinal epithelium and for the distribution of the metal to tissues, while ATP7B performs a central function in the hepatocyte, in the incorporation of copper into cuproproteins, and in the biliary excretion of excess.
Wilson's disease represents the most important clinical example of impaired hepatic copper metabolism. It is caused by mutations that reduce or alter the function of ATP7B. The initial consequence is a reduced ability of the hepatocyte to eliminate copper through bile and to correctly incorporate it into proteins destined for secretion.
Copper therefore tends to progressively accumulate in the liver. In an initial phase, this accumulation can be compensated by intracellular binding and sequestration systems, including metallothioneins. When, however, the compensatory capacity is exceeded, the fraction of copper capable of participating in harmful reactions increases.
Liver damage associated with copper accumulation can be sustained by several mechanisms: alteration of mitochondrial function, damage to proteins, modifications of lipid metabolism, and increased oxidative stress. As the disease progresses, copper can also accumulate in other tissues, in particular in the central nervous system, contributing to the appearance of neurological and psychiatric manifestations.
Wilson's disease demonstrates particularly effectively why copper cannot be considered simply a beneficial or harmful mineral. Its biological function depends on the quantity, chemical form, intracellular localization, and the efficiency of the systems that regulate its traffic.
Menkes disease, on the other hand, represents the main example of an alteration linked to an ATP7A defect. In this condition, copper can remain trapped in some cellular compartments, while the systemic and tissue availability of the metal is insufficient. The consequence is a functional deficiency of the numerous cuproproteins necessary for the development and functioning of the organism.
The clinical manifestations of Menkes disease are particularly severe because copper is indispensable during the development of the nervous system, connective tissue, and other biological systems. The disease represents an example of the close relationship between intracellular copper transport and the function of copper-dependent enzymes.
Acquired copper deficiency can also produce clinically relevant consequences. Although a primary nutritional deficiency is relatively uncommon in populations with access to a varied diet, deficiencies can occur in conditions characterized by malabsorption, inadequately balanced artificial nutrition, bariatric surgery, or alterations in mineral absorption and interaction.
Among the most important manifestations of copper deficiency are anemia and neutropenia. Anemia can be explained, at least in part, by the role of copper and copper-dependent ferroxidases in the mobilization and transport of iron. An insufficient availability of copper can therefore compromise the physiological utilization of iron even when the dietary intake of the latter is not necessarily reduced.
The evaluation of a possible copper deficiency therefore requires an integrated clinical and laboratory approach. The simple presence of anemia does not allow the problem to be automatically attributed to an iron or copper deficiency, as hematological metabolism is regulated by numerous interdependent factors.
At the other extreme, excess copper can be toxic. The greatest risk does not derive from the normal physiological presence of copper bound to its proteins, but from the loss of the mechanisms that limit its reactivity. When the quantity of copper available in forms that are not adequately sequestered or compartmentalized increases, the metal can promote harmful redox reactions.
Copper can participate in processes that promote the oxidation of lipids, proteins, and other macromolecules. Cell membranes, particularly rich in lipids susceptible to oxidative processes, can represent important targets of damage. Mitochondria can also be vulnerable, considering both their role in energy management and the close relationship between copper and the respiratory chain.
More recent research has also identified specific mechanisms through which altered intracellular copper availability can influence cell survival. Among these, cuproptosis has been described, a form of regulated cell death linked to the presence of copper and mitochondrial metabolism. Although these mechanisms are the subject of intense research and should not be automatically transferred to all conditions of copper exposure, they highlight how delicate the balance is between physiological necessity and metal toxicity.
From a physiological perspective, one of the most fascinating aspects of copper biochemistry is that the metal is used by the body without ever being left truly free. Copper must be continuously transferred from one protein to another, incorporated into the catalytic sites of enzymes, sequestered when in excess, and eliminated when it exceeds the body's capacity to utilize and store it.
Copper homeostasis can therefore be described as an integrated network consisting of at least five levels: intestinal absorption, blood transport, cellular uptake, intracellular distribution, and elimination.
The intestine regulates the initial entry of copper into the body. The blood helps distribute it to the liver and other tissues. Cell membranes use specialized transporters, such as CTR1, to allow the metal to enter the cells. Inside the cells, chaperones such as ATOX1 and CCS direct copper to specific destinations. Finally, the liver, through ATP7B and biliary excretion, plays a crucial role in eliminating excess copper.
This system makes it possible to balance two seemingly opposing requirements: making copper available for essential biological reactions while simultaneously preventing its chemical reactivity from damaging cells.
The liver therefore plays a central role in maintaining overall copper balance. By taking up copper from the portal circulation, utilizing it metabolically, synthesizing ceruloplasmin, distributing the metal to copper-dependent proteins, storing it safely, and excreting it through bile, the liver largely determines the amount of biologically available copper in the body.
Understanding this network also makes it possible to correctly interpret the relationship between copper, nutrition, and health. Copper should not be considered in isolation as a simple micronutrient to be increased or reduced. Its physiology depends on its relationship with iron, intestinal function, liver health, the capacity to synthesize plasma proteins, and the efficiency of intracellular transport systems.
Copper balance thus represents a prime example of trace element biochemistry: very small amounts can be essential for fundamental biological processes, while relatively modest changes in distribution or elimination can have significant consequences. Modern research continues to clarify new aspects of copper metabolism, confirming that this ancient metal, which was fundamental to the development of human civilization, remains one of the most complex and fascinating key players in the biochemistry of life.
Bibliographic references
Lutsenko S, Roy S, Tsvetkov P. Mammalian copper homeostasis: physiological roles and molecular mechanisms. Physiological Reviews. 2025;105(1):441-491. PMID: 39172219.
Gulec S, Collins JF. Molecular mediators governing iron-copper interactions. Annual Review of Nutrition. 2014;34:95-116. PMID: 24995690.
Lalioti V, Muruais G, Tsuchiya Y, Pulido D, Sandoval IV. Molecular mechanisms of copper homeostasis. Frontiers in Bioscience. 2009;14:4878-4903. PMID: 19482593.
Chen J, Jiang Y, Shi H, Peng Y, Fan X, Li C. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflügers Archiv – European Journal of Physiology. 2020;472:1415-1429. PMID: 32506322.
Helman SL, Zhou J, Fuqua BK, et al. The biology of mammalian multi-copper ferroxidases. Biometals. 2023;36:1-25. PMID: 35167013.
EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on Dietary Reference Values for copper. EFSA Journal. 2015;13(10):4253.
